Foundation
A Recap of the 2022 International Blistering Disease Consensus Group Meeting Marc Yale
T
he IPPF recently hosted a meeting with the International Blistering Disease Consensus Group at the American Academy of Dermatology (AAD) Annual Meeting on Saturday, March 26th, in Boston, MA. At the meeting, the Foundation was pleased to announce that Becky Strong, IPPF Outreach Director, will be representing the IPPF on the newly formed Global Dermatology Coalition. The mission of the Coalition is to improve patient outcomes globally by raising awareness of the impact of dermatological diseases and increasing the healthcare prioritization of these conditions. The Coalition will be providing a global platform for
interested stakeholders to take collective action to raise global awareness of the burden of dermatological conditions, put dermatology on the global health policy agenda, and build dermatology advocacy capacity globally. The Coalition will focus on: • Collating data and generating new data (as needed) on the burden of dermatological conditions • An evidence-based awareness campaign to prioritize dermatological conditions • Collective advocacy to global and regional governmental institutions (e.g., WHO) The IPPF also shared its plans to host an ExternallyLed Patient Focused Drug Development (EL-PFDD) Meeting with the Federal Drug Administration (FDA), as well as its continued commitment to crucial research projects like the IPPF Natural History Study and work with academic researchers on scientific studies.
Becky Strong, will be representing the IPPF on the newly formed Global Dermatology Coalition.
4
Quarterly | Q2 2022
www.pemphigus.org
